Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2003-01-16
2009-08-11
Vogel, Nancy (Department: 1636)
Chemistry: molecular biology and microbiology
Vector, per se
C435S325000, C514S04400A
Reexamination Certificate
active
07572628
ABSTRACT:
The present invention provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector initiation systems.
REFERENCES:
patent: 5026686 (1991-06-01), Schlesinger et al.
patent: 5091309 (1992-02-01), Schlesinger et al.
patent: 5185440 (1993-02-01), Davis et al.
patent: 5217879 (1993-06-01), Huang et al.
patent: 5466788 (1995-11-01), Alquist et al.
patent: 5505947 (1996-04-01), Johnston et al.
patent: 5532154 (1996-07-01), Brown
patent: 5578475 (1996-11-01), Jessee
patent: 5591579 (1997-01-01), Olivo et al.
patent: 5643576 (1997-07-01), Johnston et al.
patent: 5691177 (1997-11-01), Guber et al.
patent: 5739026 (1998-04-01), Garoff et al.
patent: 5766602 (1998-06-01), Xiong et al.
patent: 5789245 (1998-08-01), Dubensky, Jr. et al.
patent: 5792462 (1998-08-01), Johnston et al.
patent: 5797870 (1998-08-01), March et al.
patent: 5811407 (1998-09-01), Johnston et al.
patent: 5814482 (1998-09-01), Dubensky, Jr. et al.
patent: 5843712 (1998-12-01), Levine
patent: 5843723 (1998-12-01), Dubensky, Jr. et al.
patent: 5851757 (1998-12-01), Olivo et al.
patent: 6015686 (2000-01-01), Dubensky et al.
patent: 6342372 (2002-01-01), Dubensky, Jr. et al.
patent: 6376236 (2002-04-01), Dubensky, Jr. et al.
patent: 2200651 (1988-08-01), None
patent: WO 88/00472 (1988-01-01), None
patent: WO 89/10973 (1989-11-01), None
patent: WO 91/02805 (1991-03-01), None
patent: WO 92/06693 (1992-04-01), None
patent: WO 92/10578 (1992-06-01), None
patent: WO 94/17813 (1994-08-01), None
patent: WO 94/26912 (1994-11-01), None
patent: WO 95/07994 (1995-03-01), None
patent: WO 95/17525 (1995-06-01), None
patent: WO 95/19990 (1995-07-01), None
patent: WO 95/25788 (1995-09-01), None
patent: WO 95/27044 (1995-10-01), None
patent: WO 95/27069 (1995-10-01), None
patent: WO 95/31565 (1995-11-01), None
patent: WO 95/32733 (1995-12-01), None
patent: WO 96/17072 (1996-06-01), None
patent: WO 95/37616 (1996-11-01), None
patent: WO 96/39830 (1996-12-01), None
patent: WO 97/16169 (1997-05-01), None
patent: WO 97/24447 (1997-07-01), None
patent: WO 97/30155 (1997-08-01), None
patent: WO 97/38087 (1997-10-01), None
patent: WO 97/04446 (1997-11-01), None
patent: WO 98/13511 (1998-04-01), None
patent: WO 98/15636 (1998-04-01), None
patent: WO 98/53077 (1998-05-01), None
patent: WO 98/26084 (1998-06-01), None
patent: WO 98/36779 (1998-08-01), None
patent: WO 99/09192 (1999-02-01), None
patent: WO 99/11808 (1999-03-01), None
patent: WO 99/15641 (1999-04-01), None
patent: WO 99/18226 (1999-04-01), None
patent: WO 99/25858 (1999-05-01), None
patent: WO 99/25859 (1999-05-01), None
patent: WO 99/30734 (1999-06-01), None
Hertz et al. (J Virology, 1992, 66(2): 857-864).
Grakoui et al. (J Virology, 1989, 63(12): 5216-5227).
Ramaswamy et al. (J Virology, 1991, 65(5): 2501-2510).
Baumann and Schendel, “Interleukin-11 Regulates the Hepatic Expression of the Same Plasma Protein Genest as Interleukin-6”Journal Biological Chemistry266:20424-20427, 1991.
Beier et al., “Association of Human Class I MHC Alleles with the Adenovirus E3/19K Protein”J. Immunology152:3862-3872, 1994.
Berglund et al., “Semliki forest virus Expression System: Production of Conditionally Infectious Recombinant Particles”Bio/Technology11:916-920, 1993.
Berglund et al., “Alphavirus as Vectors for Gene Delivery”Trends in Biotechnology14:130-134, 1996.
Beuachemin et al., “Isolation and Characterization of Full-Length Functional cDNA Clones for Human Carcinoembryonic Antigen”Molecular and Cellular Biology7 (9) :3221-3230, Sep. 1987.
Boyer and Haenni, “Infectious Transcripts and cDNA Clones of RNA Viruses”Virology198:415-426, 1994.
Bredenbeek and Rice, “Animal RNA Virus Expression Systems”Seminars Virology3:297-310, 1992.
Bredenbeek et al., “Sindbis Virus Expression Vectors: Packaging of RNA Replicons by Using Defective Helper RNAs”Journal Virology67(11):6439-6446, 1993.
Browne et al., “A Complex Between the MHC Class I Homologue Encoded by Human Cytomegalovirus and Beta 2 Microglobulin”Nature347:770-772, 1990.
Davis et al., “In Vitro Synthesis of Infectious Venezuelan Equine Encephalitis Virus RNA from a cDNA Clone: Analysis of a Viable Deletion Mutant”Virology171:189-204, 1989.
Davis et al., “Protection Against Influenza in Mice by Vaccination with a Venezuelan Equine Encephaltitis Virus Vector Expressing the HA Protein”J. Cell Biochem. Suppl. 19A 310, Abstract No. J2-308, 1995.
Dubensky et al., “Sindbis Virus DNA-Based Expression Vectors: Utility for in vitro and in vivo Gene Transfer”Journal Virology70(1):508-519, 1996.
Dubuisson and Rice, “Sindbis Virus Attachment: Isolation and Characterization of Mutants with Impaired Binding to Vertebrate Cells”J. Virology67(6):3363.
Frolov and Schlesinger, “Comparison of the Effects of Sindbis Virus and Sindbis Virus Replicons on Host Cell Protein Synthesis and Cytopathogenicity in BHK Cells”J. Virology68(3):1721.
Gassman et al., “Analysis of theBorrelia burgdorferiGeHo fla Gene and Antigenic Characterization of its Gene Product”J. Bacteriology173(4):1452.
Geigenmuller-Gnirke et al., “Complementation between Sinbis Viral RNAs Produces Infectious Particles with a Bipartite Genome”Proc. Natl. Acad. Sci. USA88:3253-3257, 1991.
Grakoui et al., “A cis-Acting Mutation in the Sindbis Virus Junction Region which Affects Subgenomic RNA Synthesis”Journal Virology63 (12) :5216-5227, 1989.
Hahn et al., “Infectious Sindbis Virus Transient Expression Vectors for Studying Antigen Proccessing and Presentation”Proc. Natl. Acad. Sci. USA89:2679-2683, Apr. 1992.
Hertz and Huang, “Utilization of Heterologous Alphavirus Junction Sequences as Promoters by Sindbis Virus”Journal Virology66(2):857-864, 1992.
Herweijer et al., A Plasmid-Based Self-Amplifying Sindbis Virus Vector:Human Gene Therapy6:1161-1167, 1995.
Huang et al., “RNA Viruses as Gene Expression Vectors”Virus Genes3(1):85-91, 1989.
Huang et al., “Liposomal Gene Delivery: a Complex Package”Nature Biotechnology15:620 621, 1997.
Johanning et al., “A Sindbis Virus mRNA Polynucleotide Vector Achieves Prolonged and High Level Heterologous Gene Expression in vivo”Nucleic Acids Research23(9):1495-1501, 1995.
Kuhn et al., “Infectious RNA Transcription from Ross River Virus cDNA Clones and, the Construction and Characterization of Defined Chimeras with Sindbis Virus”Virology182:430-441, 1991.
Kuo et al., “An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis”Science244:362-364, 1989.
Lemm et al., “Mutations which Alter the Level or Structure of nsP4 can Affect the Efficiency of Sindbis Virus Replicatin in a Host-Dependent Manner”J. Virology64(6):3001-3011, 1990.
Lemm et al., “Polypeptide Requirements for Assembly of Functional Sindbis Virus Replication Complexes: a Model for the Temporal Regulation of Minus- and Plus-Strand RNA Syntheses”The EMBO J. 13(12):2925-2934, 1994.
Levis et al., “Deletion Mapping of Sindbis Virus DI RNAs Derived from cDNAs Defines the Sequences Essential for Replication and Packaging”Cell44:137-145, 1986.
Levis et al., “Engineered Defective Interfering RNAs of Sindbis Virus Express Bacterial Chloramphenicol Acetyltransferase in Avian Cells”Proc. Natl. Acad. Sci. USA84:4811-4815, 1987.
Levis et al., “Promoter for Sindbis Virus RNA-Dependent Subgenomic RNA Transcription”J. Virology64(4):1726-1733, 1990.
Liljestrom and Garoff, “A New Generation of Animal Cell Expression Vectors Based on the Semliki Forest Virus Replicon”Bio/Technology9:1356-1361, 1991.
Liljestrom, “Alphavirus Expression Systems”Current Opinion in Biotechnology5:495-500, 1994.
London et al., “Infectious Enveloped RNA Virus Antigenic Chimeras&#
Belli Barbara A.
Chang Stephen M. W.
Driver David A.
Dubensky, Jr. Thomas W.
Ibanez Carlos E.
Joike Michele K.
Lee Helen
Novartis Vaccines and Diagnostics Inc.
Vogel Nancy
LandOfFree
Eukaryotic layered vector initiation systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Eukaryotic layered vector initiation systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eukaryotic layered vector initiation systems will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4136616